Every few years, a mid-size generic manufacturer files a Paragraph IV certification against a blockbuster drug, gets sued by a […]

Pharmaceutical patent litigation produces more text per dollar at stake than almost any other legal domain. A single Hatch-Waxman case

The conventional wisdom in generic pharmaceuticals is seductive in its simplicity: be first, win big. File first, launch first, collect

Every commercial contract negotiation in pharmaceuticals has a clock running in the background. That clock is the patent expiry date,

The first generic filer gets the headlines. The second entrant often gets the margin. In the United States pharmaceutical market,

The pharmaceutical patent system was designed for a different drug. A small molecule, synthesized in a lab, dosed the same

Quick Summary: Traditional pharmaceutical market research tells you what happened yesterday. A patent analyst suite tells you what will happen

A competitor’s pipeline is not a secret. It is a public record, filed in tranches at the USPTO, EPO, and

GW Pharmaceuticals spent roughly two decades and hundreds of millions of dollars turning cannabis extracts into regulated pharmaceuticals. When Jazz